Global Conjunctivitis Therapeutics Market 2019-2023
SKU ID : TNV-14770452 | Publishing Date : 04-Feb-2019 | No. of pages : 115
Detailed TOC of Global Conjunctivitis Therapeutics Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Allergic conjunctivitis - Market size and forecast 2018-2023
• Bacterial conjunctivitis - Market size and forecast 2018-2023
• Viral conjunctivitis - Market size and forecast 2018-2023
• Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• ROW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Akorn, Incorporated
• ALLERGAN
• Bausch Health
• Novartis AG
• Santen Pharmaceutical Co., Ltd.
PART 13: APPENDIX
• Research methodology
• List of abbreviations
Exhibit 01: Years in consideration
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Type - Market share 2018-2023 (%)
Exhibit 19: Comparison by type
Exhibit 20: Allergic conjunctivitis - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Allergic conjunctivitis - Year-over-year growth 2019-2023 (%)
Exhibit 22: Bacterial conjunctivitis - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Bacterial conjunctivitis - Year-over-year growth 2019-2023 (%)
Exhibit 24: Viral conjunctivitis - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Viral conjunctivitis - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by type
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America - Year-over-year growth 2019-2023 (%)
Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Decision framework
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Akorn, Incorporated - Vendor overview
Exhibit 48: Akorn, Incorporated - Business segments
Exhibit 49: Akorn, Incorporated - Organizational developments
Exhibit 50: Akorn, Incorporated - Segment focus
Exhibit 51: Akorn, Incorporated - Key offerings
Exhibit 52: Akorn, Incorporated - Key customers
Exhibit 53: ALLERGAN - Vendor overview
Exhibit 54: ALLERGAN - Product segments
Exhibit 55: ALLERGAN - Organizational developments
Exhibit 56: ALLERGAN - Geographic focus
Exhibit 57: ALLERGAN - Segment focus
Exhibit 58: ALLERGAN - Key offerings
Exhibit 59: ALLERGAN - Key customers
Exhibit 60: Bausch Health - Vendor overview
Exhibit 61: Bausch Health - Business segments
Exhibit 62: Bausch Health - Organizational developments
Exhibit 63: Bausch Health - Geographic focus
Exhibit 64: Bausch Health - Segment focus
Exhibit 65: Bausch Health - Key offerings
Exhibit 66: Bausch Health - Key customers
Exhibit 67: Novartis AG - Vendor overview
Exhibit 68: Novartis AG - Business segments
Exhibit 69: Novartis AG - Organizational developments
Exhibit 70: Novartis AG - Geographic focus
Exhibit 71: Novartis AG - Segment focus
Exhibit 72: Novartis AG - Key offerings
Exhibit 73: Novartis AG - Key customers
Exhibit 74: Santen Pharmaceutical Co., Ltd. - Vendor overview
Exhibit 75: Santen Pharmaceutical Co., Ltd. - Business segments
Exhibit 76: Santen Pharmaceutical Co., Ltd. - Organizational developments
Exhibit 77: Santen Pharmaceutical Co., Ltd. - Geographic focus
Exhibit 78: Santen Pharmaceutical Co., Ltd. - Segment focus
Exhibit 79: Santen Pharmaceutical Co., Ltd. - Key offerings
Exhibit 80: Santen Pharmaceutical Co., Ltd. - Key customers
Exhibit 81: Validation techniques employed for market sizing
Exhibit 82: List of abbreviations
Keyplayers in Global Conjunctivitis Therapeutics Market 2019-2023
Akorn IncorporatedALLERGAN
Bausch Health
Novartis AG
and Santen Pharmaceutical Co.
Ltd.